WeVote
Log In

Bill

Bill

A 1195

Relates to mandatory health insurance coverage for follow-up screening or diagnostic services for lung cancer

2025 Regular Session Introduced by Harry Bronson and 27 co-sponsors

Bill A 1195 mandates health insurance coverage for lung cancer follow-up screenings and diagnostics, improving access and reducing costs for patients needing care.

DELIVERED TO GOVERNOR
0
WeVote Research Nonpartisan
Bill Summary · A 1195

Summary of Bill A 1195

Bill Information

  • Bill Number: A 1195
  • Title: Relates to mandatory health insurance coverage for follow-up screening or diagnostic services for lung cancer
  • Status: Returned to Assembly
  • Introduced: January 09, 2025
  • Classification: Bill

Purpose and Intent

Bill A 1195 aims to ensure that health insurance providers are required to cover follow-up screening and diagnostic services specifically for lung cancer. The intent is to improve early detection and treatment of lung cancer, which is one of the leading causes of cancer-related deaths. By mandating insurance coverage for these services, the bill seeks to reduce financial barriers for patients and promote timely medical interventions.

Key Provisions

  • Mandatory Coverage: The bill stipulates that health insurance policies must include coverage for follow-up screenings and diagnostic services for lung cancer.
  • Scope of Services: The specific types of screenings and diagnostic tests that would be covered are not detailed in the provided information but are typically expected to include imaging tests (like CT scans) and biopsies as necessary.
  • Patient Accessibility: By mandating coverage, the bill aims to make these critical services more accessible to patients who may otherwise delay or forgo necessary follow-up care due to cost concerns.

Affected Parties

  • Patients: Individuals diagnosed with lung cancer or those at high risk will benefit from reduced out-of-pocket costs for necessary follow-up care.
  • Health Insurance Providers: Insurance companies will be required to adjust their policies to comply with the new coverage mandates.
  • Healthcare Providers: Medical professionals involved in the diagnosis and treatment of lung cancer will see changes in the way they bill for follow-up services.

Legislative Actions and Timeline

  • January 09, 2025: Bill introduced and referred to the Insurance Committee.
  • May 16, 2025: The bill was amended and recommitted to the Insurance Committee.
  • May 21, 2025:
    • Reported out of committee and ordered to third reading.
    • Passed in the Assembly and delivered to the Senate.
  • May 29, 2025:
    • Substituted for S2000A and passed in the Senate.
    • Returned to the Assembly for further consideration.

Related Bills

  • A 10429: A prior-session bill that may address similar issues related to lung cancer screening.
  • S 2000: A companion bill in the Senate that aligns with the objectives of A 1195.

Conclusion

Bill A 1195 represents a significant step towards improving lung cancer care by mandating insurance coverage for essential follow-up screenings and diagnostic services. Its passage could lead to better health outcomes for patients through increased access to necessary medical interventions. The bill is currently returned to the Assembly for further legislative action.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.